Hermine Brunner
Pediatric Rheumatology · Cincinnati, OHNPI 1124011259
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $433,013 of the $531,061 with a category attached, or 81.5%. 24 manufacturers reported payments, led by Pfizer at 39.3% of the total. Reporting peaked in 2022 at $187,265 and has fallen 91.2% since, to $16,548 in 2025. Among pediatric rheumatology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 303 payments — averaging $1752.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$209K
- Janssen Research & Development, LLC$139K
- Novartis$31K
- Genentech USA, Inc.$27K
- GSK$22K
- E.r. Squibb & Sons, L.L.C.$20K
- plus $83K from 18 others
Across 419 payments — averaging $11,669 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$2.3M
- Novartis$800K
- AbbVie$350K
- E.r. Squibb & Sons, L.L.C.$287K
- GSK$257K
- Novartis Pharma AG$228K
- plus $653K from 11 others
What the payments were for
- Consulting fees$433,01382%
- Speaking & faculty fees$76,12714%
- Travel & lodging$17,9183%
- Food & beverage$3,4241%
- Education$5790%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 77 | $208,819 |
| Janssen Research & Development, LLC | 30 | $139,158 |
| Novartis | 37 | $30,735 |
| Genentech USA, Inc. | 25 | $27,298 |
| GSK | 31 | $22,452 |
| E.r. Squibb & Sons, L.L.C. | 16 | $19,979 |
| Eli Lilly | 18 | $19,556 |
| Novartis Pharma AG | 3 | $14,720 |
| EMD Serono, Inc. | 3 | $8,348 |
| Astrazeneca UK Limited | 5 | $7,958 |
| Boehringer Ingelheim International GmbH | 2 | $7,032 |
| Roche Products Limited | 2 | $6,920 |
| UCB SA | 3 | $6,840 |
| AbbVie | 28 | $4,432 |
| Merck | 1 | $1,700 |
| AstraZeneca | 5 | $1,670 |
| Bristol Myers Squibb | 1 | $1,098 |
| Biogen | 1 | $788 |
| EMD Serono Research & Development Institute, Inc. | 1 | $530 |
| Fresenius Kabi USA, LLC | 2 | $386 |
| F. Hoffmann-la Roche AG | 2 | $333 |
| Sobi, Inc | 2 | $130 |
| Amgen | 7 | $117 |
| UCB, Inc. | 1 | $63 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$531,061 in reported general payments places this provider in the 95th percentile of 35 pediatric rheumatology providers in Ohio.
Other pediatric rheumatology in Cincinnati
- Daniel LovellCincinnati$92K
- Alexei GromCincinnati$63K
- Grant SchulertCincinnati$45K
- Tracy TingCincinnati$2K
- Michael MattCincinnati$1K
- Michael HenricksonCincinnati$764
- Esi MorganCincinnati$750
- Jennifer HugginsCincinnati$609
- McKenzie VaterCincinnati$579
- Ivanna RomankevychCincinnati$576
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.